Patent directory · USPTO A61K / A61P
Patents matching “cells”
914 pharma patents match "cells" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 914 pharmaceutical patents matching "cells" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 10000551
Chimeric polypeptides, polynucleotides encoding same, cells expressing same and methods of producing same
granted -
US 9993503
Methods for production of platelets from pluripotent stem cells and compositions thereof
granted -
US 9993502
Genetically-modified cells comprising a modified human T cell receptor alpha constant region gene
granted -
US 9993537
Methods and compositions related to Th-1 dendritic cells
granted -
US 9994817
Use of ligands for the programmed cell death receptor conjugated to solid supports for cultivating human regulatory T cells
granted -
US 9993501
Genetically-modified cells comprising a modified human T cell receptor alpha constant region gene
granted -
US 9988602
Methods for producing enucleated erythroid cells derived from pluripotent stem cells
granted -
US 9987377
Targeted gene delivery to non-phagocytic mammalian cells via bacterially derived intact minicells
granted -
US 9988603
Large scale generation of functional megakaryocytes and platelets from human embryonic stem cells under stromal-free conditions
granted -
US 9969975
Genetically-modified cells comprising a modified human T cell receptor alpha constant region gene
granted -
US 9951353
Engineering neural stem cells using homologous recombination
granted -
US 9951118
Engineering antiviral T cell immunity through stem cells and chimeric antigen receptors
granted -
US 9950011
Genetically-modified cells comprising a modified human T cell receptor alpha constant region gene
granted -
US 9950010
Genetically-modified cells comprising a modified human T cell receptor alpha constant region gene
granted -
US 9938500
Hemangio-colony forming cells
granted -
US 9931418
Compositions for the delivery of RNA and drugs into cells
granted -
US 9918983
Suicidal LSD1 inhibitors targeting SOX2-expressing cancer cells
granted -
US 9907820
Polyclonal gamma delta T cells for immunotherapy
granted -
US 9889161
Genetically-modified cells comprising a modified human T cell receptor alpha constant region gene
granted -
US 9889160
Genetically-modified cells comprising a modified human T cell receptor alpha constant region gene
granted -
US 9888673
Genetically modified cells, tissues, and organs for treating disease
granted -
US 9885014
Re-conditioned serum-free culture medium composition obtained by culturing mammalian cells in Fibromodulin
granted -
US 9884076
Optimized methods for generation of cardiac stem cells from cardiac tissue and their use in cardiac therapy
granted -
US 9878043
Targeted delivery of drugs, therapeutic nucleic acids and functional nucleic acids to mammalian cells via intact killed bacterial cells
granted